The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases ...

Frontera Global, a behavioural intelligence consultancy that connects research, strategy and medical communications to help ...

That plurality matters because the strongest answer rarely comes from one point of view, but from several being tested ...

A year after its initial launch as QuintilesIMS, the pharma service provider has re-launched as IQVIA. Its new name maintains parts of its original formation, with the ‘I’ representing IMS and the ‘Q’ ...

Eli Lilly has entered into an agreement to acquire Dice Therapeutics for approximately $2.4bn, marking a significant boost to its immunology pipeline. The deal grants Lilly access to the biopharma’s ...

Khougazian most recently served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering ...

Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to ...

At eight years of follow-up, results showed that Tagrisso continued to show an OS benefit, reducing the risk of death ...

Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical ...

Imfinzi is approved in the US, EU, Japan, China and many other countries around the world as the standard-of-care treatment ...

How does a healthcare system assess the value of innovation, whether in the form of new diagnostics, devices, medicines or other technology?

Johnson & Johnson (J&J) has announced that the National Institute for Health and Care Excellence (NICE) has published Final ...